Daniel Warmenhoven

Dec 02, 2016

Theranos has appointed Daniel Warmenhoven to its board of directors, effective immediately. Warmenhoven has served in various positions with many companies in the technology industry, including as CEO of NetApp and as executive chairman of the NetApp board of directors. He has also served as chairman, president, and CEO of Network Equipment Technologies, and has held senior management positions at Hewlett-Packard and IBM. He is currently a director on the boards of Bechtel Group and Palo Alto Networks. Warmenhoven is replacing retiring director Riley P. Bechtel, who is stepping down because of health issues. 

Theranos also announced that it will retire its Board of Counselors as part of an ongoing restructuring of its corporate advisory framework.

More Like This

Jul 26, 2017

Scott Howell

Tenet Diagnostics has appointed Scott Howell its CMO. He was most recently executive medical director at Heritage Provider Network. He also continues to practice at Kaiser Permanente Los Angeles Medical Center in the addiction medicine department. He was previously national senior medical director and chief medical officer Network and Population Health, Optim Insight, regional CMO Northeast region of Americhoice, and national medical director of managed care for AIDS Healthcare Foundation. 

Jul 25, 2017

David Barka, Nikhil Vazirani

Erba Diagnostics said that effective Aug. 1, David Barka will become the interim CEO and Nikhil Vazirani will join the firm's board. Barka has been the vice president of Calbiotech since 2004, and as president of Calbiotech Veterinary Diagnostics since 2017. He also has been president of Microplate Dispensers, dba Moduline Systems, since 2013. He plans to continue serving in those roles, Erba said. Vazirani has been the managing director of Erba Diagnostics Mannheim since April 2016, and a director of Erba Diagnostics UK and the interim CEO of Erba Lachema since this past February. He plans to continue serving in those roles. 

Jul 24, 2017

Richard Wenstrup

Richard Wenstrup was appointed CMO of Oxford Immunotec. He has more than 20 years of clinical leadership experience, including more than a decade in the diagnostics space. Wenstrup was most recently executive vice president and CMO of Myriad Genetics. Previously, he was CMO of Myraid Genetic Laboratories. 

Jul 24, 2017

Kieran Murphy, Stephen Kanovsky

Kieran Murphy has resigned from the board of NeoGenomics following his appointment as president and CEO of GE Healthcare. NeoGenomics said in a document filed with the US Securities and Exchange Commission that Murphy resigned due to the time demands of his new job, and added that it has appointed Stephen Kanovsky to fill Murphy's position on the board. He is general counsel of GE unit Global Innovation of GE Healthcare.

Jul 21, 2017

Thomas Loewald

Thomas Loewald, senior vice president and chief commercial officer at Thermo Fisher Scientific since early 2016, will resign from the company, effective September 1. He joined the firm's Explosives Detection business in 2002 and held various positions over the years, including senior vice president and president of Laboratory Products. Prior to that, he was vice president of sales and marketing for Tyco International.

Jul 20, 2017

Mark Stevenson

Mark Stevenson has been promoted to executive vice president and chief operation officer of Thermo Fisher Scientific, effective August 1. In his new role, he will oversee operations of the company's Laboratory Products and Analytical Instruments businesses, in addition to the Life Sciences Solutions business. Since 2014, when Thermo Fisher acquired Life Technologies, Stevenson has been executive vice president and president of Life Sciences Solutions. Prior to that, he was president and chief operating officer of Life Technologies, and before that, he was president and COO of Applied Biosystems.

Jul 19, 2017

Lew Titterton

Lew Titterton has rejoined the board of Itus. He was previously on the firm's board from 2010 to 2016, and was its chairman during the last four years of his previous tenure. He was also a director at Itus between 1999 and 2003. Titterton is currently chairman of the board at NYMED.

Jul 18, 2017

Anna Chérouvrier Hansson, Henrik Appelgren

Anna Chérouvrier Hansson is joining SenzaGen as the firm's chief commercial officer, and Henrik Appelgren will become its chief scientific officer. The firm said that the appointments are the final steps as it prepares to commercialize its GARD tests and to list on the Nasdaq First North. Hansson most recently was the director of marketing at Camurus. She begins her new job on Aug. 15. Appelgren has been with the Swedish Chemicals Agency for 15 years, where he was Sweden's national coordinator in the OECD Test Guideline Programme. He joins SenzaGen on Sept. 4. 

 

Jul 17, 2017

Stephen Pereira

Stephen Pereira has been appointed to Immunovia's scientific advisory board. Pereira is a professor of hepatology and gastroenterology at University College London and is an honorary consultant in pancreaticobiliary medicine at UCL Hospitals and the Royal Free Hospital. 

Jul 07, 2017

Matthias Raquet

Oneservice, a Swiss company offering complete managed service solutions, consulting, and learning for the life science, diagnostics, and medical device industries, has appointed Matthias Raquet as CEO. Raquet joins Oneservice from Qiagen, where he has worked since 2001, most recently as vice president and head of global service solutions and global customer management. Prior to Qiagen he worked in various management roles at Amersham Pharmacia.

Jul 07, 2017

Amit Kumar, Robert Berman, Mike Catelani

Amit Kumar was named president and CEO of Itus, which is developing blood-based solid tumor cancer diagnostics. He replaces Robert Berman, who resigned as president, CEO, and as a director. Kumar, formerly CEO of CombiMatrix, has been the executive chairman of Itus for the past year, and has been a director since joining the firm in 2012. Also, Mike Catelani, Itus' CFO, has been promoted to chief operating officer. 

Jul 06, 2017

Richard Davis

Qualigen announced Richard Davis has been elected to its board, effective June 26. David is an associate clinical professor of urology at the David Geffen School of Medicine at the University of California, Los Angeles, as well as chief of surgery at Motion Picture and Television Hospital. He is on the staff of several hospitals, as well. 

Jul 06, 2017

Gail Page

Gail Page has joined the board of Chembio Diagnostics. Page is the founder of Vineyard Investment Advisors, and previously was president and CEO of Vermillion. She also served as executive vice president and COO of Luminex. 

Jul 05, 2017

Patrick Kennedy

Former Congressman Patrick Kennedy has joined the board of Medibio, an Australian firm developing biomarker-based tests for the diagnosis and management of mental disorders, including depression and chronic stress. Kennedy was an eight-term member of Congress, where he represented Rhode Island. 

 

Jul 05, 2017

Chad Brown

NanoString Technologies has appointed Chad Brown senior vice president of sales and marketing. With more than 35 years of experience in life science tools and clinical diagnostics, Brown most recently served as the president and head of commercial operations for North America at Qiagen. Prior to that, Brown was with Roche Diagnostics Corporation, where he held a series of commercial leadership positions in the applied sciences and centralized diagnostics businesses. He has also held sales leadership positions in several medical device and healthcare companies, including Chiron Diagnostics, Rotech Healthcare, Apria Healthcare, and Humana.

Brown succeeds Barney Saunders, who is expected to stay with NanoString for a three-month transition period before pursuing other professional opportunities.